FDA OKs Blood-Based Test to Help Diagnose Prostate Cancer

Medscape·Dec 3

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The FDA has approved a blood-based test to help diagnose prostate cancer. The test is intended to aid in the detection of high-grade prostate tumors, particularly in cases with elevated PSA levels. However, some reports mention unrelated FDA approvals, including a urine-based multi-cancer detection test and other diagnostic tools, which may not be directly related to the prostate cancer blood test.

Full coverage

FDA Approves Novel Blood-Based Prostate Cancer Test for Elevated PSA Levels

CancerNetwork·Dec 2

FDA OKs Blood-Based Test to Help Detect High-Grade Prostate Tumors

MedPage Today·Dec 1

FDA Approves IsoPSA Blood-Based Prostate Cancer Test as Diagnostic Aid for High-Risk Disease

OncLive·Dec 1

FDA Breakthrough Designation Granted to Urine-Based Multi-Cancer Early Detection Test

Medical Product Outsourcing·Jul 6

Fetching the latest headlines…

FDA OKs Blood-Based Test to Help Diagnose Prostate Cancer

Full coverage

FDA Approves Novel Blood-Based Prostate Cancer Test for Elevated PSA Levels

FDA OKs Blood-Based Test to Help Detect High-Grade Prostate Tumors

FDA Approves IsoPSA Blood-Based Prostate Cancer Test as Diagnostic Aid for High-Risk Disease

FDA Breakthrough Designation Granted to Urine-Based Multi-Cancer Early Detection Test

FDA OKs prostate cancer PSA test from Cleveland Diagnostics

FDA OKs Updated Guardant360 Liquid CDx with Expanded Molecular Profiling

FDA-approved Alzheimer's blood test could be a 'game-changer'

FDA OKs QuidelOrtho’s Gel-Based Direct Antiglobulin Testing Card